Literature DB >> 30141114

Non-Coding RNA Pvt1 Promotes Cancer Stem Cell-Like Traits in Nasopharyngeal Cancer via Inhibiting miR-1207.

Meng Cui1, Yu Chang2, Qi-Gen Fang1, Wei Du1, Jun-Fu Wu1, Ji-Heng Wang1, Shan-Ting Liu1, Su-Xia Luo3.   

Abstract

Nasopharyngeal carcinoma (NPC) is a kind of head-neck malignant tumor. lncRNA-PVT1 can promote the proliferation of carcinoma cells, and induce cells to have stem cell-like potentials. However, the function of PVT1 in NPC cells is not clear. The expressions of lncRNA-PVT1 and the expressions of the stem cell markers in NPC tissues or cell lines were investigated by qRT-PCR or western blot. The cell proliferation, and the ability of NPC cells to form spherical, clonal colonies were investigated by MTT assay, colony formation assay, and tumor-sphere formation assay. Cancer stem cells surface markers were detected by flow cytometry and western blot. PI3K/AKT signal activation in NPC cells was determined by western blot. PVT1 was significantly up-regulated in both NPC tissues and cell lines and associated with poor prognosis. PVT1 knockdown reduced NPC cells viability, clonogenicity, the cell surface CD44+/CD24- stem phenotype, and the expressions of the stem cell markers in NPC cells, including Oct4, c-Myc, SOX2, and ALDH. Furthermore, PVT1 negatively regulates the expression levels of miR-1207 in NPC cells and spheres cells, which is critical for NPC stemness. Knockdown of miR-1207 promoted stem phenotype and the expressions of the stem cell markers in NPC cells. Moreover, phosphor-PI3K (p-PI3K) and phosphor-AKT (p-AKT) were found to be down-regulated after PVT1 siRNAs transfection in NPC cells. And miR-1207 inhibitor transfection reversed the all the effects brought by PVT1 knockdown. Pvt1 promotes cancer stem cell-like properties in NPC cells via inhibiting miR-1207 and activating the PI3K/AKT signal pathway.

Entities:  

Keywords:  Nasopharyngeal carcinoma; PI3K/AKT; PVT1; Tumor stem cell; miR-1207

Mesh:

Substances:

Year:  2018        PMID: 30141114     DOI: 10.1007/s12253-018-0453-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  46 in total

Review 1.  Long non-coding RNA PVT1 and cancer.

Authors:  Ming Cui; Lei You; Xiaoxia Ren; Wenjing Zhao; Quan Liao; Yupei Zhao
Journal:  Biochem Biophys Res Commun       Date:  2016-02-03       Impact factor: 3.575

Review 2.  PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application.

Authors:  Pu Xia; Xiao-Yan Xu
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.

Authors:  Wen Wen; Tao Han; Cheng Chen; Lei Huang; Wen Sun; Xue Wang; Shu-Zhen Chen; Dai-Min Xiang; Liang Tang; Dan Cao; Gen-Sheng Feng; Meng-Chao Wu; Jin Ding; Hong-Yang Wang
Journal:  Mol Cancer Ther       Date:  2013-06-26       Impact factor: 6.261

4.  Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas.

Authors:  B A Ruggeri; L Huang; M Wood; J Q Cheng; J R Testa
Journal:  Mol Carcinog       Date:  1998-02       Impact factor: 4.784

Review 5.  Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity.

Authors:  Adriana Albini; Antonino Bruno; Cristina Gallo; Giorgio Pajardi; Douglas M Noonan; Katiuscia Dallaglio
Journal:  Connect Tissue Res       Date:  2015-08-20       Impact factor: 3.417

6.  Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy.

Authors:  M Lucrecia Alvarez; Mahdieh Khosroheidari; Elena Eddy; Jeff Kiefer
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

7.  Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer.

Authors:  Jian Ding; Dan Li; Minzhen Gong; Jinpo Wang; Xunru Huang; Ting Wu; Chengdang Wang
Journal:  Onco Targets Ther       Date:  2014-09-18       Impact factor: 4.147

Review 8.  Long Noncoding RNA Regulation of Pluripotency.

Authors:  Alessandro Rosa; Monica Ballarino
Journal:  Stem Cells Int       Date:  2015-11-30       Impact factor: 5.443

9.  Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells.

Authors:  Chengle Zhuang; Jianfa Li; Yuchen Liu; Mingwei Chen; Jiancheng Yuan; Xing Fu; Yonghao Zhan; Li Liu; Junhao Lin; Qing Zhou; Wen Xu; Guoping Zhao; Zhiming Cai; Weiren Huang
Journal:  Oncotarget       Date:  2015-12-01

Review 10.  LncRNAs in Stem Cells.

Authors:  Shanshan Hu; Ge Shan
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

View more
  9 in total

Review 1.  Cancer stem cells: a major culprit of intra-tumor heterogeneity.

Authors:  Faiza Naz; Mengran Shi; Salvia Sajid; Zhao Yang; Changyuan Yu
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

2.  Knockdown of long non-coding RNA PVT1 inhibits the proliferation of Raji cells through cell cycle regulation.

Authors:  Chanli Zheng; Yu Xiao; Yangqiu Li; Dongmei He
Journal:  Oncol Lett       Date:  2019-06-07       Impact factor: 2.967

Review 3.  CircPVT1: a pivotal circular node intersecting Long Non-Coding-PVT1 and c-MYC oncogenic signals.

Authors:  Alina Catalina Palcau; Valeria Canu; Sara Donzelli; Sabrina Strano; Claudio Pulito; Giovanni Blandino
Journal:  Mol Cancer       Date:  2022-01-28       Impact factor: 27.401

Review 4.  Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities.

Authors:  Haihua Wang; Weiyuan Wang; Songqing Fan
Journal:  Int J Biol Sci       Date:  2022-03-28       Impact factor: 10.750

Review 5.  Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer.

Authors:  Weiping Yao; Shuang Li; Ruiqi Liu; Mingyun Jiang; Liang Gao; Yanwei Lu; Xiaodong Liang; Haibo Zhang
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

Review 6.  lncRNA PVT1: a novel oncogene in multiple cancers.

Authors:  Ruiming Li; Xia Wang; Chunming Zhu; Kefeng Wang
Journal:  Cell Mol Biol Lett       Date:  2022-10-04       Impact factor: 8.702

Review 7.  Regulatory Mechanisms and Clinical Applications of the Long Non-coding RNA PVT1 in Cancer Treatment.

Authors:  Meng-Yuan Li; Xiao-Huan Tang; Yan Fu; Tie-Jun Wang; Jia-Ming Zhu
Journal:  Front Oncol       Date:  2019-08-21       Impact factor: 6.244

Review 8.  Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer.

Authors:  Ariadna Boloix; Marc Masanas; Carlos Jiménez; Roberta Antonelli; Aroa Soriano; Josep Roma; Josep Sánchez de Toledo; Soledad Gallego; Miguel F Segura
Journal:  Front Oncol       Date:  2019-11-06       Impact factor: 6.244

9.  FBXL19‑AS1 promotes the progression of nasopharyngeal carcinoma by acting as a competing endogenous RNA to sponge miR‑431 and upregulate PBOV1.

Authors:  Hongjun Dong; Chao Huang; Jingjing Huang
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.